Feb 12 (Reuters)-
Immuno Biological Laboratories Co Ltd
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
9 months ended 9 months ended Year to
Dec 31, 2020 Dec 31, 2019 Mar 31, 2021
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 414 mln 389 mln 549 mln
(+6.3 pct) (-32.6 pct) (-4.8 pct)
Operating loss 230 mln loss 298 mln loss 308 mln
Recurring loss 299 mln loss 350 mln loss 410 mln
Net loss 303 mln loss 337 mln loss 430 mln
EPS loss 32.61 yen loss 38.67 yen loss 46.16 yen
Ann Div NIL NIL
-Q2 div NIL NIL
-Q4 div NIL NIL
NOTE - Immuno Biological Laboratories Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4570.T